In this study, we leveraged recently developed biased small-molecule activators of PP2A (SMAPs) (30–32) to explore the role of B56-containing PP2As in regulation of 4E-BPs and to evaluate the potential of PP2A reactivation for restoring translational control in tumor cells. This evidence concerns the gene PTPA and neoplasm.